nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—ABCC1—Vemurafenib—skin cancer	0.084	0.11	CbGbCtD
Conjugated Estrogens—ABCG2—Vismodegib—skin cancer	0.0711	0.0929	CbGbCtD
Conjugated Estrogens—ABCC3—Fluorouracil—skin cancer	0.0615	0.0803	CbGbCtD
Conjugated Estrogens—ABCG2—Vemurafenib—skin cancer	0.0562	0.0735	CbGbCtD
Conjugated Estrogens—ABCC1—Dactinomycin—skin cancer	0.0558	0.0729	CbGbCtD
Conjugated Estrogens—ABCC4—Fluorouracil—skin cancer	0.047	0.0614	CbGbCtD
Conjugated Estrogens—CYP1A2—Imiquimod—skin cancer	0.0423	0.0553	CbGbCtD
Conjugated Estrogens—SLCO1B3—Docetaxel—skin cancer	0.0417	0.0545	CbGbCtD
Conjugated Estrogens—ABCG2—Dactinomycin—skin cancer	0.0374	0.0488	CbGbCtD
Conjugated Estrogens—ABCC1—Docetaxel—skin cancer	0.0288	0.0377	CbGbCtD
Conjugated Estrogens—ABCB1—Vismodegib—skin cancer	0.0256	0.0335	CbGbCtD
Conjugated Estrogens—ABCG2—Fluorouracil—skin cancer	0.0253	0.033	CbGbCtD
Conjugated Estrogens—CYP1A2—Vemurafenib—skin cancer	0.0232	0.0303	CbGbCtD
Conjugated Estrogens—CYP3A4—Imiquimod—skin cancer	0.0222	0.029	CbGbCtD
Conjugated Estrogens—CYP3A4—Temozolomide—skin cancer	0.0222	0.029	CbGbCtD
Conjugated Estrogens—ABCC2—Docetaxel—skin cancer	0.0213	0.0279	CbGbCtD
Conjugated Estrogens—ABCG2—Docetaxel—skin cancer	0.0193	0.0252	CbGbCtD
Conjugated Estrogens—CYP1A2—Dacarbazine—skin cancer	0.0178	0.0232	CbGbCtD
Conjugated Estrogens—CYP3A4—Vismodegib—skin cancer	0.0154	0.0201	CbGbCtD
Conjugated Estrogens—ABCB1—Dactinomycin—skin cancer	0.0135	0.0176	CbGbCtD
Conjugated Estrogens—CYP3A4—Vemurafenib—skin cancer	0.0121	0.0159	CbGbCtD
Conjugated Estrogens—CYP1A2—Fluorouracil—skin cancer	0.0104	0.0136	CbGbCtD
Conjugated Estrogens—ABCB1—Docetaxel—skin cancer	0.00695	0.00909	CbGbCtD
Conjugated Estrogens—CYP3A4—Docetaxel—skin cancer	0.00417	0.00544	CbGbCtD
Conjugated Estrogens—COMT—Dopamine metabolism—TYR—skin cancer	0.00175	0.219	CbGpPWpGaD
Conjugated Estrogens—ABCC11—female reproductive system—skin cancer	0.00152	0.04	CbGeAlD
Conjugated Estrogens—COMT—hair follicle—skin cancer	0.00149	0.0391	CbGeAlD
Conjugated Estrogens—SLCO3A1—nipple—skin cancer	0.00131	0.0344	CbGeAlD
Conjugated Estrogens—SLC51A—female reproductive system—skin cancer	0.00122	0.0321	CbGeAlD
Conjugated Estrogens—SLCO4A1—nipple—skin cancer	0.00119	0.0314	CbGeAlD
Conjugated Estrogens—ESR2—neck—skin cancer	0.00105	0.0275	CbGeAlD
Conjugated Estrogens—ABCC1—hair follicle—skin cancer	0.00104	0.0272	CbGeAlD
Conjugated Estrogens—SLC51A—head—skin cancer	0.00102	0.0268	CbGeAlD
Conjugated Estrogens—COMT—nipple—skin cancer	0.00101	0.0265	CbGeAlD
Conjugated Estrogens—ESR1—blood vessel—skin cancer	0.001	0.0264	CbGeAlD
Conjugated Estrogens—SLC10A1—female reproductive system—skin cancer	0.000793	0.0208	CbGeAlD
Conjugated Estrogens—SLCO3A1—mammalian vulva—skin cancer	0.000766	0.0201	CbGeAlD
Conjugated Estrogens—ESR2—connective tissue—skin cancer	0.000751	0.0197	CbGeAlD
Conjugated Estrogens—SLC22A11—female reproductive system—skin cancer	0.000724	0.019	CbGeAlD
Conjugated Estrogens—ESR1—neck—skin cancer	0.000718	0.0189	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—skin cancer	0.000716	0.0188	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—skin cancer	0.000713	0.0187	CbGeAlD
Conjugated Estrogens—ABCC1—nipple—skin cancer	0.000702	0.0184	CbGeAlD
Conjugated Estrogens—SLCO4A1—mammalian vulva—skin cancer	0.000698	0.0183	CbGeAlD
Conjugated Estrogens—SLC10A1—head—skin cancer	0.000662	0.0174	CbGeAlD
Conjugated Estrogens—SLCO3A1—female reproductive system—skin cancer	0.000656	0.0172	CbGeAlD
Conjugated Estrogens—COMT—skin of body—skin cancer	0.000647	0.017	CbGeAlD
Conjugated Estrogens—SLCO1C1—head—skin cancer	0.000623	0.0164	CbGeAlD
Conjugated Estrogens—SLCO4A1—female reproductive system—skin cancer	0.000597	0.0157	CbGeAlD
Conjugated Estrogens—COMT—mammalian vulva—skin cancer	0.00059	0.0155	CbGeAlD
Conjugated Estrogens—CYP1A2—nipple—skin cancer	0.000559	0.0147	CbGeAlD
Conjugated Estrogens—ESR2—lymphoid tissue—skin cancer	0.000549	0.0144	CbGeAlD
Conjugated Estrogens—SLCO3A1—head—skin cancer	0.000548	0.0144	CbGeAlD
Conjugated Estrogens—ESR2—female reproductive system—skin cancer	0.00053	0.0139	CbGeAlD
Conjugated Estrogens—SLCO1B1—female reproductive system—skin cancer	0.000526	0.0138	CbGeAlD
Conjugated Estrogens—ESR1—connective tissue—skin cancer	0.000514	0.0135	CbGeAlD
Conjugated Estrogens—COMT—female reproductive system—skin cancer	0.000505	0.0133	CbGeAlD
Conjugated Estrogens—SLCO4A1—head—skin cancer	0.000499	0.0131	CbGeAlD
Conjugated Estrogens—ABCC3—female reproductive system—skin cancer	0.000499	0.0131	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—skin cancer	0.000488	0.0128	CbGeAlD
Conjugated Estrogens—SLCO2B1—female reproductive system—skin cancer	0.000465	0.0122	CbGeAlD
Conjugated Estrogens—ESR2—head—skin cancer	0.000443	0.0116	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—skin cancer	0.000436	0.0115	CbGeAlD
Conjugated Estrogens—COMT—head—skin cancer	0.000422	0.0111	CbGeAlD
Conjugated Estrogens—ABCC3—head—skin cancer	0.000417	0.0109	CbGeAlD
Conjugated Estrogens—ABCC4—female reproductive system—skin cancer	0.000412	0.0108	CbGeAlD
Conjugated Estrogens—ABCC1—mammalian vulva—skin cancer	0.00041	0.0108	CbGeAlD
Conjugated Estrogens—ABCC2—female reproductive system—skin cancer	0.000398	0.0105	CbGeAlD
Conjugated Estrogens—ABCB1—blood vessel—skin cancer	0.000396	0.0104	CbGeAlD
Conjugated Estrogens—SLCO2B1—head—skin cancer	0.000388	0.0102	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—skin cancer	0.000384	0.0101	CbGeAlD
Conjugated Estrogens—ESR1—lymphoid tissue—skin cancer	0.000376	0.00988	CbGeAlD
Conjugated Estrogens—ESR1—female reproductive system—skin cancer	0.000363	0.00953	CbGeAlD
Conjugated Estrogens—SLCO1A2—head—skin cancer	0.000357	0.00939	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—skin cancer	0.000349	0.00918	CbGeAlD
Conjugated Estrogens—ABCC4—head—skin cancer	0.000344	0.00904	CbGeAlD
Conjugated Estrogens—SLC22A8—head—skin cancer	0.000341	0.00897	CbGeAlD
Conjugated Estrogens—ABCG2—mammalian vulva—skin cancer	0.000339	0.00892	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—skin cancer	0.00031	0.00814	CbGeAlD
Conjugated Estrogens—ESR1—head—skin cancer	0.000303	0.00796	CbGeAlD
Conjugated Estrogens—ABCC3—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000299	0.0374	CbGpPWpGaD
Conjugated Estrogens—COMT—lymph node—skin cancer	0.000295	0.00776	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—skin cancer	0.000292	0.00767	CbGeAlD
Conjugated Estrogens—ABCC4—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000281	0.0351	CbGpPWpGaD
Conjugated Estrogens—Erythema—Bleomycin—skin cancer	0.000277	0.00147	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Imiquimod—skin cancer	0.000277	0.00147	CcSEcCtD
Conjugated Estrogens—Infestation—Fluorouracil—skin cancer	0.000276	0.00146	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Fluorouracil—skin cancer	0.000276	0.00146	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Vemurafenib—skin cancer	0.000275	0.00146	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Imiquimod—skin cancer	0.000275	0.00146	CcSEcCtD
Conjugated Estrogens—Fatigue—Imiquimod—skin cancer	0.000275	0.00146	CcSEcCtD
Conjugated Estrogens—Visual disturbance—Docetaxel—skin cancer	0.000273	0.00145	CcSEcCtD
Conjugated Estrogens—Pain—Imiquimod—skin cancer	0.000273	0.00144	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Fluorouracil—skin cancer	0.000272	0.00144	CcSEcCtD
Conjugated Estrogens—SLCO2B1—lymph node—skin cancer	0.000272	0.00714	CbGeAlD
Conjugated Estrogens—Renal impairment—Docetaxel—skin cancer	0.000272	0.00144	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Fluorouracil—skin cancer	0.000271	0.00143	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Fluorouracil—skin cancer	0.000271	0.00143	CcSEcCtD
Conjugated Estrogens—Dermatitis bullous—Docetaxel—skin cancer	0.00027	0.00143	CcSEcCtD
Conjugated Estrogens—Asthenia—Vemurafenib—skin cancer	0.000268	0.00142	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Temozolomide—skin cancer	0.000268	0.00142	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Temozolomide—skin cancer	0.000267	0.00141	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Temozolomide—skin cancer	0.000265	0.0014	CcSEcCtD
Conjugated Estrogens—Pruritus—Vemurafenib—skin cancer	0.000264	0.0014	CcSEcCtD
Conjugated Estrogens—Alopecia—Dactinomycin—skin cancer	0.000263	0.00139	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Imiquimod—skin cancer	0.000261	0.00138	CcSEcCtD
Conjugated Estrogens—Visual impairment—Temozolomide—skin cancer	0.000259	0.00137	CcSEcCtD
Conjugated Estrogens—Sinusitis—Fluorouracil—skin cancer	0.000259	0.00137	CcSEcCtD
Conjugated Estrogens—Erythema—Dactinomycin—skin cancer	0.000259	0.00137	CcSEcCtD
Conjugated Estrogens—Pain in extremity—Docetaxel—skin cancer	0.000258	0.00137	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Vemurafenib—skin cancer	0.000256	0.00136	CcSEcCtD
Conjugated Estrogens—Migraine—Docetaxel—skin cancer	0.000254	0.00135	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Temozolomide—skin cancer	0.000254	0.00135	CcSEcCtD
Conjugated Estrogens—Urticaria—Imiquimod—skin cancer	0.000253	0.00134	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Imiquimod—skin cancer	0.000252	0.00134	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Imiquimod—skin cancer	0.000252	0.00134	CcSEcCtD
Conjugated Estrogens—Eye disorder—Temozolomide—skin cancer	0.000251	0.00133	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Temozolomide—skin cancer	0.00025	0.00132	CcSEcCtD
Conjugated Estrogens—ESR2—Ovarian Infertility Genes—MLH1—skin cancer	0.000249	0.0311	CbGpPWpGaD
Conjugated Estrogens—Rhinitis—Fluorouracil—skin cancer	0.000248	0.00132	CcSEcCtD
Conjugated Estrogens—Dizziness—Vemurafenib—skin cancer	0.000247	0.00131	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Fluorouracil—skin cancer	0.000246	0.00131	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Fluorouracil—skin cancer	0.000246	0.0013	CcSEcCtD
Conjugated Estrogens—Angiopathy—Temozolomide—skin cancer	0.000244	0.00129	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Temozolomide—skin cancer	0.000243	0.00129	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Temozolomide—skin cancer	0.000242	0.00128	CcSEcCtD
Conjugated Estrogens—Cough—Bleomycin—skin cancer	0.000242	0.00128	CcSEcCtD
Conjugated Estrogens—ABCC4—lymph node—skin cancer	0.000241	0.00633	CbGeAlD
Conjugated Estrogens—Dehydration—Docetaxel—skin cancer	0.00024	0.00127	CcSEcCtD
Conjugated Estrogens—Vomiting—Vemurafenib—skin cancer	0.000238	0.00126	CcSEcCtD
Conjugated Estrogens—Alopecia—Temozolomide—skin cancer	0.000238	0.00126	CcSEcCtD
Conjugated Estrogens—Chest pain—Bleomycin—skin cancer	0.000236	0.00125	CcSEcCtD
Conjugated Estrogens—Myalgia—Bleomycin—skin cancer	0.000236	0.00125	CcSEcCtD
Conjugated Estrogens—Rash—Vemurafenib—skin cancer	0.000236	0.00125	CcSEcCtD
Conjugated Estrogens—Mental disorder—Temozolomide—skin cancer	0.000236	0.00125	CcSEcCtD
Conjugated Estrogens—Dermatitis—Vemurafenib—skin cancer	0.000235	0.00125	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Imiquimod—skin cancer	0.000235	0.00124	CcSEcCtD
Conjugated Estrogens—Headache—Vemurafenib—skin cancer	0.000234	0.00124	CcSEcCtD
Conjugated Estrogens—Erythema—Temozolomide—skin cancer	0.000234	0.00124	CcSEcCtD
Conjugated Estrogens—Malnutrition—Temozolomide—skin cancer	0.000234	0.00124	CcSEcCtD
Conjugated Estrogens—Breast disorder—Docetaxel—skin cancer	0.000234	0.00124	CcSEcCtD
Conjugated Estrogens—ABCC2—lymph node—skin cancer	0.000233	0.00612	CbGeAlD
Conjugated Estrogens—Cramp muscle—Docetaxel—skin cancer	0.000233	0.00123	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Temozolomide—skin cancer	0.000229	0.00121	CcSEcCtD
Conjugated Estrogens—Asthenia—Imiquimod—skin cancer	0.000229	0.00121	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Bleomycin—skin cancer	0.000226	0.0012	CcSEcCtD
Conjugated Estrogens—Oedema—Bleomycin—skin cancer	0.000226	0.0012	CcSEcCtD
Conjugated Estrogens—Back pain—Temozolomide—skin cancer	0.000226	0.0012	CcSEcCtD
Conjugated Estrogens—Pruritus—Imiquimod—skin cancer	0.000226	0.00119	CcSEcCtD
Conjugated Estrogens—Infection—Bleomycin—skin cancer	0.000225	0.00119	CcSEcCtD
Conjugated Estrogens—Dysphagia—Docetaxel—skin cancer	0.000223	0.00118	CcSEcCtD
Conjugated Estrogens—Nausea—Vemurafenib—skin cancer	0.000222	0.00118	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Fluorouracil—skin cancer	0.000221	0.00117	CcSEcCtD
Conjugated Estrogens—Vision blurred—Temozolomide—skin cancer	0.000221	0.00117	CcSEcCtD
Conjugated Estrogens—Myalgia—Dactinomycin—skin cancer	0.00022	0.00117	CcSEcCtD
Conjugated Estrogens—Bronchospasm—Docetaxel—skin cancer	0.00022	0.00116	CcSEcCtD
Conjugated Estrogens—Alopecia—Fluorouracil—skin cancer	0.000219	0.00116	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Imiquimod—skin cancer	0.000218	0.00116	CcSEcCtD
Conjugated Estrogens—Anorexia—Bleomycin—skin cancer	0.000216	0.00114	CcSEcCtD
Conjugated Estrogens—Erythema—Fluorouracil—skin cancer	0.000216	0.00114	CcSEcCtD
Conjugated Estrogens—Angioedema—Temozolomide—skin cancer	0.000214	0.00113	CcSEcCtD
Conjugated Estrogens—ESR1—lymph node—skin cancer	0.000212	0.00558	CbGeAlD
Conjugated Estrogens—Hypotension—Bleomycin—skin cancer	0.000212	0.00112	CcSEcCtD
Conjugated Estrogens—Oedema—Dactinomycin—skin cancer	0.000211	0.00112	CcSEcCtD
Conjugated Estrogens—Dizziness—Imiquimod—skin cancer	0.000211	0.00112	CcSEcCtD
Conjugated Estrogens—Vertigo—Temozolomide—skin cancer	0.00021	0.00111	CcSEcCtD
Conjugated Estrogens—Infection—Dactinomycin—skin cancer	0.00021	0.00111	CcSEcCtD
Conjugated Estrogens—Palpitations—Temozolomide—skin cancer	0.000207	0.0011	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000206	0.00109	CcSEcCtD
Conjugated Estrogens—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000206	0.0258	CbGpPWpGaD
Conjugated Estrogens—ABCC1—lymph node—skin cancer	0.000205	0.0054	CbGeAlD
Conjugated Estrogens—Cough—Temozolomide—skin cancer	0.000204	0.00108	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Bleomycin—skin cancer	0.000203	0.00108	CcSEcCtD
Conjugated Estrogens—Weight increased—Docetaxel—skin cancer	0.000203	0.00108	CcSEcCtD
Conjugated Estrogens—Vision blurred—Fluorouracil—skin cancer	0.000203	0.00108	CcSEcCtD
Conjugated Estrogens—Convulsion—Temozolomide—skin cancer	0.000203	0.00107	CcSEcCtD
Conjugated Estrogens—Vomiting—Imiquimod—skin cancer	0.000203	0.00107	CcSEcCtD
Conjugated Estrogens—CYP3A4—female reproductive system—skin cancer	0.000202	0.00532	CbGeAlD
Conjugated Estrogens—Dyspnoea—Bleomycin—skin cancer	0.000202	0.00107	CcSEcCtD
Conjugated Estrogens—Anorexia—Dactinomycin—skin cancer	0.000201	0.00107	CcSEcCtD
Conjugated Estrogens—Rash—Imiquimod—skin cancer	0.000201	0.00106	CcSEcCtD
Conjugated Estrogens—Dermatitis—Imiquimod—skin cancer	0.000201	0.00106	CcSEcCtD
Conjugated Estrogens—Headache—Imiquimod—skin cancer	0.0002	0.00106	CcSEcCtD
Conjugated Estrogens—Myalgia—Temozolomide—skin cancer	0.000199	0.00106	CcSEcCtD
Conjugated Estrogens—Arthralgia—Temozolomide—skin cancer	0.000199	0.00106	CcSEcCtD
Conjugated Estrogens—Infestation—Docetaxel—skin cancer	0.000199	0.00106	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Docetaxel—skin cancer	0.000199	0.00106	CcSEcCtD
Conjugated Estrogens—Anxiety—Temozolomide—skin cancer	0.000199	0.00105	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000198	0.00105	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Bleomycin—skin cancer	0.000197	0.00104	CcSEcCtD
Conjugated Estrogens—Acute coronary syndrome—Docetaxel—skin cancer	0.000196	0.00104	CcSEcCtD
Conjugated Estrogens—Renal failure—Docetaxel—skin cancer	0.000196	0.00104	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Docetaxel—skin cancer	0.000195	0.00103	CcSEcCtD
Conjugated Estrogens—Myocardial infarction—Docetaxel—skin cancer	0.000195	0.00103	CcSEcCtD
Conjugated Estrogens—Pain—Bleomycin—skin cancer	0.000194	0.00103	CcSEcCtD
Conjugated Estrogens—ABCB1—epithelium—skin cancer	0.000193	0.00507	CbGeAlD
Conjugated Estrogens—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000192	0.00102	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Temozolomide—skin cancer	0.000191	0.00101	CcSEcCtD
Conjugated Estrogens—Oedema—Temozolomide—skin cancer	0.000191	0.00101	CcSEcCtD
Conjugated Estrogens—Infection—Temozolomide—skin cancer	0.00019	0.00101	CcSEcCtD
Conjugated Estrogens—Nausea—Imiquimod—skin cancer	0.000189	0.001	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Docetaxel—skin cancer	0.000188	0.000998	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Temozolomide—skin cancer	0.000187	0.000993	CcSEcCtD
Conjugated Estrogens—Convulsion—Fluorouracil—skin cancer	0.000187	0.00099	CcSEcCtD
Conjugated Estrogens—Skin disorder—Temozolomide—skin cancer	0.000186	0.000983	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Temozolomide—skin cancer	0.000185	0.000978	CcSEcCtD
Conjugated Estrogens—Myalgia—Fluorouracil—skin cancer	0.000184	0.000973	CcSEcCtD
Conjugated Estrogens—Chest pain—Fluorouracil—skin cancer	0.000184	0.000973	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Dactinomycin—skin cancer	0.000184	0.000973	CcSEcCtD
Conjugated Estrogens—Fatigue—Dactinomycin—skin cancer	0.000182	0.000965	CcSEcCtD
Conjugated Estrogens—Anorexia—Temozolomide—skin cancer	0.000182	0.000965	CcSEcCtD
Conjugated Estrogens—Pain—Dactinomycin—skin cancer	0.000181	0.000957	CcSEcCtD
Conjugated Estrogens—Urticaria—Bleomycin—skin cancer	0.00018	0.000953	CcSEcCtD
Conjugated Estrogens—Rhinitis—Docetaxel—skin cancer	0.000179	0.00095	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Bleomycin—skin cancer	0.000179	0.000949	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Docetaxel—skin cancer	0.000178	0.000943	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Docetaxel—skin cancer	0.000177	0.00094	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Docetaxel—skin cancer	0.000176	0.000933	CcSEcCtD
Conjugated Estrogens—Oedema—Fluorouracil—skin cancer	0.000176	0.000933	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Fluorouracil—skin cancer	0.000176	0.000933	CcSEcCtD
Conjugated Estrogens—Infection—Fluorouracil—skin cancer	0.000175	0.000926	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000174	0.000922	CcSEcCtD
Conjugated Estrogens—Insomnia—Temozolomide—skin cancer	0.000173	0.000915	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Dactinomycin—skin cancer	0.000173	0.000915	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Fluorouracil—skin cancer	0.000173	0.000915	CcSEcCtD
Conjugated Estrogens—Visual impairment—Docetaxel—skin cancer	0.000172	0.000913	CcSEcCtD
Conjugated Estrogens—Tachycardia—Fluorouracil—skin cancer	0.000172	0.00091	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Temozolomide—skin cancer	0.000172	0.000909	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Temozolomide—skin cancer	0.00017	0.000902	CcSEcCtD
Conjugated Estrogens—ABCG2—lymph node—skin cancer	0.00017	0.00447	CbGeAlD
Conjugated Estrogens—Somnolence—Temozolomide—skin cancer	0.00017	0.0009	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Docetaxel—skin cancer	0.000169	0.000896	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Temozolomide—skin cancer	0.000168	0.000891	CcSEcCtD
Conjugated Estrogens—Anorexia—Fluorouracil—skin cancer	0.000168	0.000889	CcSEcCtD
Conjugated Estrogens—ABCB1—mammalian vulva—skin cancer	0.000167	0.0044	CbGeAlD
Conjugated Estrogens—Eye disorder—Docetaxel—skin cancer	0.000167	0.000885	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Dactinomycin—skin cancer	0.000167	0.000885	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Dactinomycin—skin cancer	0.000167	0.000885	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Bleomycin—skin cancer	0.000167	0.000884	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Temozolomide—skin cancer	0.000166	0.00088	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Docetaxel—skin cancer	0.000166	0.000879	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Temozolomide—skin cancer	0.000165	0.000874	CcSEcCtD
Conjugated Estrogens—Fatigue—Temozolomide—skin cancer	0.000165	0.000873	CcSEcCtD
Conjugated Estrogens—Hypotension—Fluorouracil—skin cancer	0.000164	0.000871	CcSEcCtD
Conjugated Estrogens—Pain—Temozolomide—skin cancer	0.000163	0.000866	CcSEcCtD
Conjugated Estrogens—Constipation—Temozolomide—skin cancer	0.000163	0.000866	CcSEcCtD
Conjugated Estrogens—Asthenia—Bleomycin—skin cancer	0.000162	0.000861	CcSEcCtD
Conjugated Estrogens—Angiopathy—Docetaxel—skin cancer	0.000162	0.00086	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Docetaxel—skin cancer	0.000162	0.000856	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Docetaxel—skin cancer	0.000161	0.000854	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00016	0.00085	CcSEcCtD
Conjugated Estrogens—Pruritus—Bleomycin—skin cancer	0.00016	0.000849	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Docetaxel—skin cancer	0.00016	0.000846	CcSEcCtD
Conjugated Estrogens—Insomnia—Fluorouracil—skin cancer	0.000159	0.000843	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Fluorouracil—skin cancer	0.000158	0.000837	CcSEcCtD
Conjugated Estrogens—Alopecia—Docetaxel—skin cancer	0.000158	0.000837	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Fluorouracil—skin cancer	0.000157	0.000831	CcSEcCtD
Conjugated Estrogens—Mental disorder—Docetaxel—skin cancer	0.000157	0.00083	CcSEcCtD
Conjugated Estrogens—Somnolence—Fluorouracil—skin cancer	0.000156	0.000829	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Temozolomide—skin cancer	0.000156	0.000828	CcSEcCtD
Conjugated Estrogens—Erythema—Docetaxel—skin cancer	0.000156	0.000825	CcSEcCtD
Conjugated Estrogens—Malnutrition—Docetaxel—skin cancer	0.000156	0.000825	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Dactinomycin—skin cancer	0.000156	0.000824	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Fluorouracil—skin cancer	0.000155	0.000821	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Fluorouracil—skin cancer	0.000153	0.000811	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Docetaxel—skin cancer	0.000152	0.000808	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000152	0.000805	CcSEcCtD
Conjugated Estrogens—Urticaria—Temozolomide—skin cancer	0.000152	0.000804	CcSEcCtD
Conjugated Estrogens—Asthenia—Dactinomycin—skin cancer	0.000152	0.000803	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Temozolomide—skin cancer	0.000151	0.0008	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Temozolomide—skin cancer	0.000151	0.0008	CcSEcCtD
Conjugated Estrogens—Back pain—Docetaxel—skin cancer	0.000151	0.000798	CcSEcCtD
Conjugated Estrogens—Pain—Fluorouracil—skin cancer	0.000151	0.000797	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Docetaxel—skin cancer	0.00015	0.000793	CcSEcCtD
Conjugated Estrogens—ABCB1—lymphoid tissue—skin cancer	0.000149	0.0039	CbGeAlD
Conjugated Estrogens—SLCO3A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000147	0.0184	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Dactinomycin—skin cancer	0.000145	0.000766	CcSEcCtD
Conjugated Estrogens—Vomiting—Bleomycin—skin cancer	0.000144	0.000763	CcSEcCtD
Conjugated Estrogens—ABCB1—female reproductive system—skin cancer	0.000143	0.00377	CbGeAlD
Conjugated Estrogens—Rash—Bleomycin—skin cancer	0.000143	0.000757	CcSEcCtD
Conjugated Estrogens—Dermatitis—Bleomycin—skin cancer	0.000143	0.000756	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Temozolomide—skin cancer	0.000141	0.000746	CcSEcCtD
Conjugated Estrogens—SLCO4A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00014	0.0175	CbGpPWpGaD
Conjugated Estrogens—Urticaria—Fluorouracil—skin cancer	0.00014	0.000741	CcSEcCtD
Conjugated Estrogens—Syncope—Docetaxel—skin cancer	0.00014	0.00074	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Fluorouracil—skin cancer	0.000139	0.000737	CcSEcCtD
Conjugated Estrogens—Palpitations—Docetaxel—skin cancer	0.000138	0.000729	CcSEcCtD
Conjugated Estrogens—Asthenia—Temozolomide—skin cancer	0.000137	0.000726	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Docetaxel—skin cancer	0.000137	0.000725	CcSEcCtD
Conjugated Estrogens—Cough—Docetaxel—skin cancer	0.000136	0.00072	CcSEcCtD
Conjugated Estrogens—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000136	0.017	CbGpPWpGaD
Conjugated Estrogens—Pruritus—Temozolomide—skin cancer	0.000135	0.000716	CcSEcCtD
Conjugated Estrogens—Convulsion—Docetaxel—skin cancer	0.000135	0.000715	CcSEcCtD
Conjugated Estrogens—Nausea—Bleomycin—skin cancer	0.000135	0.000713	CcSEcCtD
Conjugated Estrogens—Vomiting—Dactinomycin—skin cancer	0.000134	0.000712	CcSEcCtD
Conjugated Estrogens—Rash—Dactinomycin—skin cancer	0.000133	0.000706	CcSEcCtD
Conjugated Estrogens—Chest pain—Docetaxel—skin cancer	0.000133	0.000702	CcSEcCtD
Conjugated Estrogens—Arthralgia—Docetaxel—skin cancer	0.000133	0.000702	CcSEcCtD
Conjugated Estrogens—Myalgia—Docetaxel—skin cancer	0.000133	0.000702	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000132	0.000697	CcSEcCtD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000131	0.0164	CbGpPWpGaD
Conjugated Estrogens—Diarrhoea—Temozolomide—skin cancer	0.000131	0.000693	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Fluorouracil—skin cancer	0.00013	0.000687	CcSEcCtD
Conjugated Estrogens—Oedema—Docetaxel—skin cancer	0.000127	0.000673	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Docetaxel—skin cancer	0.000127	0.000673	CcSEcCtD
Conjugated Estrogens—ESR2—Ovarian Infertility Genes—CDK4—skin cancer	0.000126	0.0158	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Temozolomide—skin cancer	0.000126	0.000669	CcSEcCtD
Conjugated Estrogens—Infection—Docetaxel—skin cancer	0.000126	0.000669	CcSEcCtD
Conjugated Estrogens—ESR1—FOXM1 transcription factor network—XRCC1—skin cancer	0.000126	0.0158	CbGpPWpGaD
Conjugated Estrogens—Nausea—Dactinomycin—skin cancer	0.000125	0.000665	CcSEcCtD
Conjugated Estrogens—Shock—Docetaxel—skin cancer	0.000125	0.000662	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Docetaxel—skin cancer	0.000125	0.00066	CcSEcCtD
Conjugated Estrogens—Pruritus—Fluorouracil—skin cancer	0.000125	0.00066	CcSEcCtD
Conjugated Estrogens—Tachycardia—Docetaxel—skin cancer	0.000124	0.000657	CcSEcCtD
Conjugated Estrogens—Skin disorder—Docetaxel—skin cancer	0.000123	0.000654	CcSEcCtD
Conjugated Estrogens—Vomiting—Temozolomide—skin cancer	0.000121	0.000644	CcSEcCtD
Conjugated Estrogens—Anorexia—Docetaxel—skin cancer	0.000121	0.000642	CcSEcCtD
Conjugated Estrogens—Rash—Temozolomide—skin cancer	0.00012	0.000638	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Fluorouracil—skin cancer	0.00012	0.000638	CcSEcCtD
Conjugated Estrogens—Dermatitis—Temozolomide—skin cancer	0.00012	0.000638	CcSEcCtD
Conjugated Estrogens—ABCB1—head—skin cancer	0.00012	0.00315	CbGeAlD
Conjugated Estrogens—Headache—Temozolomide—skin cancer	0.00012	0.000634	CcSEcCtD
Conjugated Estrogens—ABCC11—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000119	0.0149	CbGpPWpGaD
Conjugated Estrogens—Hypotension—Docetaxel—skin cancer	0.000119	0.000629	CcSEcCtD
Conjugated Estrogens—SLCO1C1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000118	0.0147	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Fluorouracil—skin cancer	0.000116	0.000617	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000116	0.000613	CcSEcCtD
Conjugated Estrogens—Insomnia—Docetaxel—skin cancer	0.000115	0.000609	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Docetaxel—skin cancer	0.000114	0.000604	CcSEcCtD
Conjugated Estrogens—Nausea—Temozolomide—skin cancer	0.000113	0.000601	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Docetaxel—skin cancer	0.000113	0.0006	CcSEcCtD
Conjugated Estrogens—Somnolence—Docetaxel—skin cancer	0.000113	0.000598	CcSEcCtD
Conjugated Estrogens—Vomiting—Fluorouracil—skin cancer	0.000112	0.000593	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Docetaxel—skin cancer	0.000112	0.000593	CcSEcCtD
Conjugated Estrogens—Rash—Fluorouracil—skin cancer	0.000111	0.000588	CcSEcCtD
Conjugated Estrogens—Dermatitis—Fluorouracil—skin cancer	0.000111	0.000587	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Docetaxel—skin cancer	0.00011	0.000585	CcSEcCtD
Conjugated Estrogens—Headache—Fluorouracil—skin cancer	0.00011	0.000584	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Docetaxel—skin cancer	0.00011	0.000581	CcSEcCtD
Conjugated Estrogens—Fatigue—Docetaxel—skin cancer	0.00011	0.00058	CcSEcCtD
Conjugated Estrogens—Constipation—Docetaxel—skin cancer	0.000109	0.000576	CcSEcCtD
Conjugated Estrogens—Pain—Docetaxel—skin cancer	0.000109	0.000576	CcSEcCtD
Conjugated Estrogens—ABCC3—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000105	0.0132	CbGpPWpGaD
Conjugated Estrogens—Nausea—Fluorouracil—skin cancer	0.000105	0.000554	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Docetaxel—skin cancer	0.000104	0.00055	CcSEcCtD
Conjugated Estrogens—ESR1—FOXA1 transcription factor network—SHH—skin cancer	0.000101	0.0127	CbGpPWpGaD
Conjugated Estrogens—Abdominal pain—Docetaxel—skin cancer	0.0001	0.000532	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Docetaxel—skin cancer	0.0001	0.000532	CcSEcCtD
Conjugated Estrogens—ABCC4—Fluoropyrimidine Activity—ERCC2—skin cancer	9.89e-05	0.0124	CbGpPWpGaD
Conjugated Estrogens—Hypersensitivity—Docetaxel—skin cancer	9.36e-05	0.000496	CcSEcCtD
Conjugated Estrogens—Asthenia—Docetaxel—skin cancer	9.11e-05	0.000483	CcSEcCtD
Conjugated Estrogens—Pruritus—Docetaxel—skin cancer	8.99e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Docetaxel—skin cancer	8.69e-05	0.000461	CcSEcCtD
Conjugated Estrogens—SLCO2B1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	8.53e-05	0.0107	CbGpPWpGaD
Conjugated Estrogens—Dizziness—Docetaxel—skin cancer	8.4e-05	0.000445	CcSEcCtD
Conjugated Estrogens—ABCB1—lymph node—skin cancer	8.38e-05	0.0022	CbGeAlD
Conjugated Estrogens—Vomiting—Docetaxel—skin cancer	8.08e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Rash—Docetaxel—skin cancer	8.01e-05	0.000424	CcSEcCtD
Conjugated Estrogens—Dermatitis—Docetaxel—skin cancer	8e-05	0.000424	CcSEcCtD
Conjugated Estrogens—Headache—Docetaxel—skin cancer	7.96e-05	0.000422	CcSEcCtD
Conjugated Estrogens—SLC22A11—SLC-mediated transmembrane transport—SLC12A2—skin cancer	7.73e-05	0.00966	CbGpPWpGaD
Conjugated Estrogens—ABCC1—S1P1 pathway—PTGS2—skin cancer	7.69e-05	0.00961	CbGpPWpGaD
Conjugated Estrogens—Nausea—Docetaxel—skin cancer	7.55e-05	0.0004	CcSEcCtD
Conjugated Estrogens—SLCO3A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.47e-05	0.00935	CbGpPWpGaD
Conjugated Estrogens—ESR1—Estrogen signaling pathway—BRAF—skin cancer	7.34e-05	0.00918	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	7.25e-05	0.00907	CbGpPWpGaD
Conjugated Estrogens—SLCO4A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.13e-05	0.00892	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	7.08e-05	0.00885	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	6.66e-05	0.00833	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	6.24e-05	0.0078	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	6.21e-05	0.00777	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6e-05	0.0075	CbGpPWpGaD
Conjugated Estrogens—SLCO1C1—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.98e-05	0.00747	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.89e-05	0.00737	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	5.89e-05	0.00736	CbGpPWpGaD
Conjugated Estrogens—ESR2—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	5.76e-05	0.00721	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Ectoderm Differentiation—SHH—skin cancer	5.42e-05	0.00678	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	5.23e-05	0.00654	CbGpPWpGaD
Conjugated Estrogens—ESR1—FOXM1 transcription factor network—CDK4—skin cancer	5.13e-05	0.00641	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	5.07e-05	0.00634	CbGpPWpGaD
Conjugated Estrogens—ESR2—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	4.96e-05	0.0062	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	4.92e-05	0.00615	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	4.47e-05	0.0056	CbGpPWpGaD
Conjugated Estrogens—SLCO2B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	4.33e-05	0.00542	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—skin cancer	4.24e-05	0.0053	CbGpPWpGaD
Conjugated Estrogens—ESR2—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	4.22e-05	0.00527	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—MSH2—skin cancer	4.02e-05	0.00503	CbGpPWpGaD
Conjugated Estrogens—SLC22A11—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.93e-05	0.00491	CbGpPWpGaD
Conjugated Estrogens—ESR1—FOXM1 transcription factor network—CDKN2A—skin cancer	3.92e-05	0.0049	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—CDK4—skin cancer	3.91e-05	0.00488	CbGpPWpGaD
Conjugated Estrogens—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	3.9e-05	0.00488	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of Telomerase—TERT—skin cancer	3.9e-05	0.00487	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.75e-05	0.00469	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Fluoropyrimidine Activity—TP53—skin cancer	3.75e-05	0.00469	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Arachidonic acid metabolism—PTGS2—skin cancer	3.54e-05	0.00443	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Fluoropyrimidine Activity—TP53—skin cancer	3.53e-05	0.00441	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.41e-05	0.00426	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.39e-05	0.00424	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.38e-05	0.00423	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	3.13e-05	0.00392	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—FOXO4—skin cancer	3.06e-05	0.00383	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.05e-05	0.00382	CbGpPWpGaD
Conjugated Estrogens—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	3.03e-05	0.00379	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3.03e-05	0.00378	CbGpPWpGaD
Conjugated Estrogens—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.99e-05	0.00374	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.97e-05	0.00371	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.95e-05	0.00369	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	2.91e-05	0.00363	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.87e-05	0.00359	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PLIN2—skin cancer	2.67e-05	0.00334	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.66e-05	0.00332	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.65e-05	0.00332	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.65e-05	0.00331	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—CDKN2A—skin cancer	2.6e-05	0.00326	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	2.59e-05	0.00324	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	2.52e-05	0.00316	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.52e-05	0.00315	CbGpPWpGaD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—BRAF—skin cancer	2.51e-05	0.00313	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	2.5e-05	0.00313	CbGpPWpGaD
Conjugated Estrogens—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.5e-05	0.00313	CbGpPWpGaD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.42e-05	0.00303	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.39e-05	0.00299	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.28e-05	0.00285	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	2.28e-05	0.00285	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.27e-05	0.00284	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.16e-05	0.0027	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—CSPG4—skin cancer	2.15e-05	0.00269	CbGpPWpGaD
Conjugated Estrogens—ESR1—LKB1 signaling events—TP53—skin cancer	2.14e-05	0.00268	CbGpPWpGaD
Conjugated Estrogens—ESR1—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	2.13e-05	0.00266	CbGpPWpGaD
Conjugated Estrogens—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.11e-05	0.00264	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.11e-05	0.00263	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PLIN2—skin cancer	2.05e-05	0.00256	CbGpPWpGaD
Conjugated Estrogens—ESR1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.94e-05	0.00242	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RHOU—skin cancer	1.94e-05	0.00242	CbGpPWpGaD
Conjugated Estrogens—COMT—Neuronal System—BRAF—skin cancer	1.92e-05	0.0024	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—CDK4—skin cancer	1.84e-05	0.0023	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PLIN2—skin cancer	1.67e-05	0.00209	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.66e-05	0.00207	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CSPG4—skin cancer	1.65e-05	0.00206	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—BRAF—skin cancer	1.63e-05	0.00204	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.57e-05	0.00196	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.53e-05	0.00191	CbGpPWpGaD
Conjugated Estrogens—ESR1—ATF-2 transcription factor network—IL6—skin cancer	1.52e-05	0.0019	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PLIN2—skin cancer	1.51e-05	0.00189	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—ENO2—skin cancer	1.46e-05	0.00183	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—TP53—skin cancer	1.45e-05	0.00181	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.45e-05	0.00181	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	1.44e-05	0.0018	CbGpPWpGaD
Conjugated Estrogens—ESR2—SIDS Susceptibility Pathways—IL6—skin cancer	1.39e-05	0.00173	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CSPG4—skin cancer	1.35e-05	0.00169	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	1.35e-05	0.00168	CbGpPWpGaD
Conjugated Estrogens—ESR1—AP-1 transcription factor network—IL6—skin cancer	1.33e-05	0.00166	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PLIN2—skin cancer	1.31e-05	0.00164	CbGpPWpGaD
Conjugated Estrogens—ESR1—Leptin signaling pathway—HRAS—skin cancer	1.31e-05	0.00164	CbGpPWpGaD
Conjugated Estrogens—ESR2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.29e-05	0.00161	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CSPG4—skin cancer	1.22e-05	0.00152	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PLIN2—skin cancer	1.18e-05	0.00148	CbGpPWpGaD
Conjugated Estrogens—COMT—Transmission across Chemical Synapses—HRAS—skin cancer	1.15e-05	0.00144	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.14e-05	0.00143	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.14e-05	0.00142	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CSPG4—skin cancer	1.14e-05	0.00142	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PLIN2—skin cancer	1.12e-05	0.0014	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—ENO2—skin cancer	1.12e-05	0.0014	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.12e-05	0.0014	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.09e-05	0.00136	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CSPG4—skin cancer	1.06e-05	0.00132	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PLIN2—skin cancer	1.04e-05	0.0013	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—NRAS—skin cancer	1.02e-05	0.00127	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.01e-05	0.00126	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	9.64e-06	0.0012	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CSPG4—skin cancer	9.53e-06	0.00119	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTCH2—skin cancer	9.45e-06	0.00118	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ENO2—skin cancer	9.16e-06	0.00115	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CSPG4—skin cancer	9.05e-06	0.00113	CbGpPWpGaD
Conjugated Estrogens—COMT—Neuronal System—HRAS—skin cancer	8.83e-06	0.0011	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—KRAS—skin cancer	8.81e-06	0.0011	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—KRAS—skin cancer	8.77e-06	0.0011	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—ERCC2—skin cancer	8.63e-06	0.00108	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—ERCC2—skin cancer	8.5e-06	0.00106	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CSPG4—skin cancer	8.38e-06	0.00105	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ENO2—skin cancer	8.27e-06	0.00103	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	8.19e-06	0.00102	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	8.07e-06	0.00101	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Breast Cancer Pathway—TP53—skin cancer	7.83e-06	0.00098	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SHH—skin cancer	7.73e-06	0.000967	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ENO2—skin cancer	7.73e-06	0.000967	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—HRAS—skin cancer	7.45e-06	0.000932	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.3e-06	0.000913	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ENO2—skin cancer	7.2e-06	0.0009	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.16e-06	0.000896	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GLI2—skin cancer	7.16e-06	0.000896	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling by ERBB4—IL6—skin cancer	7.13e-06	0.000892	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MC1R—skin cancer	6.83e-06	0.000855	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—GLI1—skin cancer	6.74e-06	0.000842	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—ERCC2—skin cancer	6.51e-06	0.000814	CbGpPWpGaD
Conjugated Estrogens—ESR1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.49e-06	0.000812	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ENO2—skin cancer	6.48e-06	0.00081	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.46e-06	0.000808	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SUFU—skin cancer	6.39e-06	0.000798	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FOXO4—skin cancer	6.3e-06	0.000788	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ENO2—skin cancer	6.16e-06	0.00077	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	5.77e-06	0.000722	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ENO2—skin cancer	5.7e-06	0.000713	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.63e-06	0.000704	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PLIN2—skin cancer	5.62e-06	0.000703	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ERCC2—skin cancer	5.32e-06	0.000665	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—NRAS—skin cancer	5.19e-06	0.00065	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTGS2—skin cancer	5.1e-06	0.000637	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.07e-06	0.000633	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SHH—skin cancer	4.87e-06	0.000609	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RASA1—skin cancer	4.84e-06	0.000605	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.81e-06	0.000602	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ERCC2—skin cancer	4.8e-06	0.0006	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTCH1—skin cancer	4.62e-06	0.000577	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SMO—skin cancer	4.62e-06	0.000577	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CSPG4—skin cancer	4.53e-06	0.000567	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTGER4—skin cancer	4.49e-06	0.000562	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERCC2—skin cancer	4.49e-06	0.000562	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PLIN2—skin cancer	4.49e-06	0.000561	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—KRAS—skin cancer	4.47e-06	0.000559	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—ERCC2—skin cancer	4.35e-06	0.000544	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TERT—skin cancer	4.21e-06	0.000527	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ERCC2—skin cancer	4.18e-06	0.000523	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—skin cancer	3.97e-06	0.000497	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FOXO4—skin cancer	3.97e-06	0.000496	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTGS2—skin cancer	3.91e-06	0.000488	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.86e-06	0.000483	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HRAS—skin cancer	3.8e-06	0.000475	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ERCC2—skin cancer	3.76e-06	0.00047	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CSPG4—skin cancer	3.62e-06	0.000453	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ERCC2—skin cancer	3.58e-06	0.000447	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PLIN2—skin cancer	3.46e-06	0.000433	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	3.43e-06	0.000429	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—BRAF—skin cancer	3.33e-06	0.000417	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ERCC2—skin cancer	3.31e-06	0.000414	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—skin cancer	3.19e-06	0.000399	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO2—skin cancer	3.08e-06	0.000385	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—skin cancer	2.88e-06	0.00036	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CSPG4—skin cancer	2.79e-06	0.000349	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—skin cancer	2.69e-06	0.000337	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—skin cancer	2.65e-06	0.000332	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—skin cancer	2.51e-06	0.000313	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO2—skin cancer	2.46e-06	0.000308	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—skin cancer	2.26e-06	0.000282	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—skin cancer	2.14e-06	0.000268	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—BRAF—skin cancer	2.1e-06	0.000263	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NRAS—skin cancer	2.1e-06	0.000262	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—skin cancer	1.98e-06	0.000248	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.92e-06	0.000241	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO2—skin cancer	1.9e-06	0.000237	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—skin cancer	1.8e-06	0.000226	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—skin cancer	1.79e-06	0.000224	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—skin cancer	1.53e-06	0.000192	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—IL6—skin cancer	1.47e-06	0.000184	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—skin cancer	1.43e-06	0.000179	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NRAS—skin cancer	1.32e-06	0.000165	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—skin cancer	1.14e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—skin cancer	1.1e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—skin cancer	1.07e-06	0.000134	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—skin cancer	1.01e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—skin cancer	9.65e-07	0.000121	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL6—skin cancer	9.24e-07	0.000116	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—skin cancer	8.57e-07	0.000107	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—skin cancer	6.61e-07	8.27e-05	CbGpPWpGaD
